Kornblau SM - Search Results

1

Reverse phase protein array profiling reveals distinct proteomic signatures associated with chronic myeloid leukemia progression and with chronic phase in the CD34-positive compartment.

Quintás-Cardama A, Qiu YH, Post SM, Zhang Y, Creighton CJ, Cortes J, Kornblau SM. Quintás-Cardama A, et al. Among authors: kornblau sm. Cancer. 2012 Nov 1;118(21):5283-92. doi: 10.1002/cncr.27568. Epub 2012 Apr 19. Cancer. 2012. PMID: 22517119 Free PMC article.

2

Clinical implications of decreased retinoblastoma protein expression in acute myelogenous leukemia.

Kornblau SM, Xu HJ, del Giglio A, Hu SX, Zhang W, Calvert L, Beran M, Estey E, Andreeff M, Trujillo J, et al. Kornblau SM, et al. Cancer Res. 1992 Sep 1;52(17):4587-90. Cancer Res. 1992. PMID: 1511426

3

Retinoblastoma protein expression is frequently altered in chronic lymphocytic leukemia.

Kornblau SM, Chen N, del Giglio A, O'Brien S, Deisseroth AB. Kornblau SM, et al. Cancer Res. 1994 Jan 1;54(1):242-6. Cancer Res. 1994. PMID: 8261446

4

Disseminated intravascular coagulation in adult acute lymphoblastic leukemia: frequent complications with fibrinogen levels less than 100 mg/dl.

Sarris A, Cortes J, Kantarjian H, Pierce S, Smith T, Keating M, Koller C, Kornblau S, O'Brien S, Andreeff M. Sarris A, et al. Leuk Lymphoma. 1996 Mar;21(1-2):85-92. doi: 10.3109/10428199609067584. Leuk Lymphoma. 1996. PMID: 8907274

5

Long-term follow-up results of alpha-interferon-based regimens in patients with late chronic phase chronic myelogenous leukemia.

Sacchi S, Kantarjian HM, O'Brien S, Beran M, Koller C, Pierce S, Kornblau S, Estey E, Keating MJ, Talpaz M. Sacchi S, et al. Leukemia. 1997 Oct;11(10):1610-6. doi: 10.1038/sj.leu.2400791. Leukemia. 1997. PMID: 9324278 Clinical Trial.

6

Results of decitabine therapy in the accelerated and blastic phases of chronic myelogenous leukemia.

Kantarjian HM, O'Brien SM, Keating M, Beran M, Estey E, Giralt S, Kornblau S, Rios MB, de Vos D, Talpaz M. Kantarjian HM, et al. Among authors: kornblau s. Leukemia. 1997 Oct;11(10):1617-20. doi: 10.1038/sj.leu.2400796. Leukemia. 1997. PMID: 9324279 Clinical Trial.

7

Early treatment decisions with interferon-alfa therapy in early chronic-phase chronic myelogenous leukemia.

Sacchi S, Kantarjian HM, Smith TL, O'Brien S, Pierce S, Kornblau S, Beran M, Keating MJ, Talpaz M. Sacchi S, et al. J Clin Oncol. 1998 Mar;16(3):882-9. doi: 10.1200/JCO.1998.16.3.882. J Clin Oncol. 1998. PMID: 9508169

8

Low and maximally phosphorylated levels of the retinoblastoma protein confer poor prognosis in newly diagnosed acute myelogenous leukemia: a prospective study.

Kornblau SM, Andreeff M, Hu SX, Xu HJ, Patel S, Theriault A, Koller C, Kantarjian H, Estey E, Deisseroth AB, Benedict WF. Kornblau SM, et al. Clin Cancer Res. 1998 Aug;4(8):1955-63. Clin Cancer Res. 1998. PMID: 9717825

9

High levels of constitutive WAF1/Cip1 protein are associated with chemoresistance in acute myelogenous leukemia.

Zhang W, Kornblau SM, Kobayashi T, Gambel A, Claxton D, Deisseroth AB. Zhang W, et al. Among authors: kornblau sm. Clin Cancer Res. 1995 Sep;1(9):1051-7. Clin Cancer Res. 1995. PMID: 9816079

10

Treatment of Philadelphia chromosome-positive early chronic phase chronic myelogenous leukemia with daily doses of interferon alpha and low-dose cytarabine.

Kantarjian HM, O'Brien S, Smith TL, Rios MB, Cortes J, Beran M, Koller C, Giles FJ, Andreeff M, Kornblau S, Giralt S, Keating MJ, Talpaz M. Kantarjian HM, et al. J Clin Oncol. 1999 Jan;17(1):284-92. doi: 10.1200/JCO.1999.17.1.284. J Clin Oncol. 1999. PMID: 10458244 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

356 results

Search Page

Filters